Loading...
U.S. Physical Therapy reported a strong first quarter in 2023, marked by record-high first quarter volume and Adjusted EBITDA, despite a decrease in net income primarily due to increased interest expenses.
Adjusted EBITDA increased to $18.5 million, an all-time high for the first quarter.
Net patient revenue from physical therapy operations increased by 15.6% to $126.6 million.
Average visits per clinic per day reached 29.8, an all-time high for the first quarter.
The company reaffirms its Adjusted EBITDA guidance for 2023 to be in the range of $75.0 million to $80.0 million.
Management reaffirms that it currently expects the Company’s Adjusted EBITDA for 2023 to be in the range of $75.0 million to $80.0 million.